photo of

Details

Role Team Leader / Clinician Scientist Fellow

Contact

Available for student supervision
Dr Gabrielle Haeusler is the Team Leader for the Clinical Infections group.
Dr Gabrielle Haeusler is the Team Leader for the Clinical Infections group.

Top Publications

  • Furlong, E, Kotecha, RS, Conyers, R, O'Brien, TA, Hansford, JR, Super, L, Downie, P, Eisenstat, DD, Haeusler, G, McMullan, B, et al. COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.. Med J Aust 216(6) : 312 -319 2022
    view publication
  • Haeusler, GM, Garnham, AL, Li-Wai-Suen, CS, Clark, JE, Babl, FE, Allaway, Z, Slavin, MA, Mechinaud, F, Smyth, GK, Phillips, B, et al. Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia.. Clin Transl Immunology 11(5) : e1383 2022
    view publication
  • Abo, Y-N, Curtis, N, Osowicki, J, Haeusler, G, Purcell, R, Kadambari, S, De Wachter, M, Vanden Driessche, K, Dekeyzer, S, Coleman, L, et al. Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis.. J Pediatric Infect Dis Soc 10(12) : 1087 -1091 2021
    view publication
  • Haeusler, GM, Ammann, RA, Carlesse, F, Groll, AH, Averbuch, D, Castagnola, E, Agyeman, PKA, Phillips, B, Gilli, F, Solopova, G, et al. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients.. Eur J Cancer 159: 78 -86 2021
    view publication
  • Reynolds, G, Haeusler, G, Slavin, MA, Teh, B, Thursky, K. Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach?. Support Care Cancer 29(11) : 6193 -6200 2021
    view publication

Page 6 of 20